Abiopharma

📋 Schuth Alexander O. (Officer) plans to sell 17K shares of Denali Therapeutics Inc. (at $16.50 each, total $284K) Filed: Jan 06, 2026 | ID: 000004

Li Yang 🟡 adjusted position in 1.1K shares (1 derivative) of Surrozen, Inc./DE (SRZN) at $19.87 Transaction Date: Jan 02, 2026 | Filing ID: 005094

📋 Watts Ryan J. (Director) plans to sell 35K shares of Denali Therapeutics Inc. (at $16.50 each, total $581K) Filed: Jan 06, 2026 | ID: 000003

Williams Charles O 🟡 adjusted position in 1.6K shares (1 derivative) of Surrozen, Inc./DE (SRZN) at $19.87 Transaction Date: Jan 02, 2026 | Filing ID: 005092

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: CureVac N.V. - Ordinary Shares.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: CureVac N.V. - Ordinary Shares.

NASDAQ traded attribute type Security_Name was changed. Previous value: CureVac N.V. - Ordinary Shares. New value: CureVac N.V. - Ordinary Shares.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Mersana Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Mersana Therapeutics, Inc. - Common Stock. New value: Mersana Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Mersana Therapeutics, Inc. - Common Stock.

Elghandour Rami 🟡 adjusted position in 208.3K shares (4 derivative) of Arcellx, Inc. (ACLX) Transaction Date: Jan 02, 2026 | Filing ID: 005086

Gilson Michelle 🟡 adjusted position in 88.5K shares (4 derivative) of Arcellx, Inc. (ACLX) Transaction Date: Jan 02, 2026 | Filing ID: 005085

WALT DAVID R 🟢 acquired 1.2K shares of Quanterix Corp (QTRX) Transaction Date: Jan 02, 2026 | Filing ID: 000001

Dambkowski Carl 🟢 acquired 83.7K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $75.78 ($6.3M) Transaction Date: Jan 02, 2026 | Filing ID: 001485

Director HENDERSON MICHAEL THOMAS 🟢 acquired 253.0K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $75.78 ($19.2M) Transaction Date: Jan 02, 2026 | Filing ID: 001484